Related Experiment Video

Updated: Jul 10, 2026

A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
04:11

A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)

Published on: June 9, 2026

Seamless Phase II/III combination study through response adaptive randomization

Lin Wang1, Lu Cui

  • 1Biostatistics and Programming, Sanofi Aventis, Bridgewater, New Jersey 08807, USA. lin.wang2@sanofi-aventis.com

Journal of Biopharmaceutical Statistics
|November 21, 2007
PubMed

Insights

This study introduces a seamless clinical trial design for drug development. It combines Phase II dose finding and Phase III confirmation, improving efficiency and reliability while controlling errors.

Area of Science:

  • Clinical Trials
  • Pharmaceutical Research
  • Biostatistics

Background:

  • Traditional drug development uses separate Phase II (dose finding) and Phase III (confirmation) studies.
  • This sequential approach is inefficient, costly, and provides limited data from Phase II.
  • There is a need for more integrated and reliable clinical trial methodologies.

Purpose of the Study:

  • To propose a seamless, adaptive clinical trial design.
  • To combine dose identification and effectiveness confirmation into a single study.
  • To enhance the efficiency and reliability of drug development processes.

Main Methods:

  • Developed a seamless design integrating Phase II and Phase III trials.
  • Utilized adaptive patient allocation for dynamic dose selection.
  • Investigated methods for controlling the type I error rate.

Main Results:

  • Simulations demonstrated successful control of the type I error rate.
  • The proposed seamless design significantly improved study efficiency.
  • Reliability of the drug development process was greatly enhanced compared to traditional methods.

Conclusions:

  • The seamless adaptive design offers a superior alternative to traditional sequential trials.
  • This integrated approach optimizes resource allocation and accelerates drug development.
  • The method provides a robust framework for both dose finding and confirmation.

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.